Pediatric Atopic Dermatitis: Navigating Patient, Provider, Caregiver Connection with Peter Lio, MD
RAD 2025. Peter Lio, MD, shares details from his presentation on shared decision making when treating children with atopic dermatitis.
At the Revolutionizing Atopic Dermatitis 2025 meeting, well known researcher Peter Lio, MD, assistant clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, IL, spoke on the connection between the patient, provider, and caregiver when seeing children with atopic dermatitis (AD). His presentation touched on shared decision-making, the role of alternative medicine for AD treatment, and personalized medication plans.
“It was a ranging discussion; I like to call it my ‘old man discussion’” Lio told Patient Care during an interview at the meeting. “It brought together a lot of the ideas that are being reinforced at the conference and brought it to how we can think about it when we’re in the room with the patient.” He goes into more detail in the short video above, taped onsite in Nashville, TN, June 6-7.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
